AVX 0.00% 2.5¢ avexa limited

whisper, page-55

  1. 1,579 Posts.
    lightbulb Created with Sketch. 300
    supertramp
    the number quoted by bioshares for viral drop is incorrect (the atc and idenix nnrti numbers are very similar), and bioshares do not refer to the difference between nrti's and nnrti's, and the issue of resistance

    fyi, nnrti's mode of action is to have a much greater short term impact on viral load, in general, than nrti's. but if only a nnrti were used, that benefit would last a very shot time and lead to a very high load of resistant virus

    the interesting thing is, even with the expected much greater shrt term viral drop of an nnrti, atc almost matched the idenix drug on the nnrti turf. atc will blow it away over a longer term (more than 3wks) in %detectable, cd4 and resistance developed

    that is why nrti's and 2 in particular, are the backbone to hiv treatment, they dont have the shrt term muscle, but lead to a longer term decline in load...

    but unfortunately resistance still eventually builds

    so the need for nrti's that act against resistance, to other nrti's and nnrti/pi..., is v high

    so, if its suggested an nnrti is going to compete intensley with an nrti addressing resistance, it shows a lack of understanding of the mode of action of the different drugs

    gltu
 
watchlist Created with Sketch. Add AVX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.